Armstrong, A. W., Hee Park, S., Chirikov, V., Nicolas, P., Wang, W.-J., Colombo, M. J. and Patel, V. (2022) “Optimizing the treatment sequence: the cumulative clinical benefit of treatment initiation with deucravacitinib versus apremilast over 52 weeks in patients with moderate to severe plaque psoriasis from the POETYK PSO-1 trial”, SKIN The Journal of Cutaneous Medicine, 6(6), p. s62. doi: 10.25251/skin.6.supp.62.